Definition
Coumermycin A₁ is an aminocoumarin antibiotic that functions as a potent inhibitor of bacterial DNA gyrase, an essential type II topoisomerase.
Overview
Coumermycin A₁ is produced by certain Streptomyces species and belongs to the same chemical family as novobiocin. By binding to the ATP‑binding domain of the GyrB subunit of DNA gyrase, the compound prevents the energy‑dependent supercoiling of DNA, thereby inhibiting bacterial replication and transcription. Because of this mechanism, coumermycin A₁ exhibits broad‑spectrum antibacterial activity, especially against Gram‑positive organisms, and is frequently employed as a molecular tool in microbiological and biochemical research to study DNA gyrase function and to select for gyrase‑resistant mutants.
Etymology / Origin
The name “coumermycin” combines “coumarin,” referring to the coumarin‑derived core structure common to this class of antibiotics, with the suffix “‑mycin,” a conventional ending for antibiotics isolated from Streptomyces bacteria. The designation “A₁” distinguishes this specific molecular variant from other related coumermycin analogues (e.g., coumermycin B, coumermycin C).
Characteristics
| Property | Information |
|---|---|
| Chemical class | Aminocoumarin antibiotic |
| Molecular architecture | Dimeric molecule composed of two aminocoumarin moieties linked through a bis‑aryl ether bridge |
| Biological target | ATP‑binding site of the GyrB subunit of bacterial DNA gyrase |
| Mode of action | Competitive inhibition of ATP binding, leading to blockade of DNA supercoiling |
| Spectrum of activity | Primarily active against Gram‑positive bacteria; activity against some Gram‑negative strains has been reported |
| Research usage | Used as a selective agent in genetic screens, as a probe for gyrase‑related studies, and as a reference compound in the development of novel DNA gyrase inhibitors |
| Production | Naturally synthesized by fermentation of Streptomyces spp.; the exact producing strain varies among reported isolates |
| Physical properties | Appears as a pale yellow solid; soluble in aqueous buffers containing organic co‑solvents (e.g., DMSO) |
Related Topics
- DNA gyrase – a type II topoisomerase essential for maintaining DNA topology in bacteria.
- Aminocoumarin antibiotics – a class that includes novobiocin, coumermycin A₁, and related compounds, characterized by a coumarin core and ATP‑competitive inhibition of gyrase.
- Novobiocin – another aminocoumarin antibiotic used clinically and frequently compared with coumermycin A₁ in mechanistic studies.
- Bacterial topoisomerase inhibitors – broader category of antimicrobial agents targeting enzymes that manage DNA supercoiling.
- Streptomyces – a genus of filamentous actinobacteria renowned for producing a wide array of clinically important antibiotics, including coumermycin A₁.
All information presented reflects current scientific consensus as of the latest available literature.